The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.
Having an mRNA COVID vaccine will not make your body produce new tumour-fighting T cells. What it might do, based on this ...
Moderna’s oncology pipeline also includes a Merck-partnered personalized cancer vaccine called intismeran autogene or ...
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...
Sanofi has dropped its respiratory syncytial virus (RSV) vaccine for toddlers after the candidate underperformed in a phase 3 ...
The American Heart Association updates recommendations for cardiac arrest, choking and overdose response, plus an unexpected ...
Key opinion leaders previously interviewed by GlobalData noted the need for more data on current RSV vaccines and their use ...
Moderna announced its decision to cease development of its vaccine mRNA-1647, which was being designed to treat birth defects ...
Dr. Hatfill said he was pushed out by Health Secretary Robert F. Kennedy Jr.’s chief of staff, who fired him when he refused ...
Dr. Steven J. Hatfill, a biosecurity expert hired by HHS Secretary Robert F. Kennedy Jr., has been fired. He was a skeptic of ...
Scientists have developed an experimental mRNA vaccine that, when combined with existing immunotherapy drugs, could 'teach' ...